Fan Li

5PUBLICATIONS
52CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 11, 2026
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

|Sep 09, 2026
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial.

|Jun 22, 2026
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.

|Nov 12, 2024
Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.

Ying Huang, Hongbo Huang, Tingting Wei

|May 11, 2022
Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype.

Fan Li, Lu Zhang, Fan Feng

Pageof 1

Frequent Collaborators

1 joint publications

Huiying Gu

1 joint publications

Yuyan Chen

1 joint publications

Mengling Zhang

1 joint publications

Qiumin Wu